Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 25 von 53

Details

Autor(en) / Beteiligte
Titel
Testing developmental toxicity in a second species: are the differences due to species or replication error?
Ist Teil von
  • Regulatory toxicology and pharmacology, 2019-10, Vol.107, p.104410, Article 104410
Ort / Verlag
Netherlands: Elsevier Inc
Erscheinungsjahr
2019
Link zum Volltext
Quelle
MEDLINE
Beschreibungen/Notizen
  • Developmental toxicity studies for chemical and pharmaceutical safety are primarily performed in rats. Regulatory frameworks may require testing in a second, non-rodent species, for which the rabbit is usually chosen. This study shows that differences in NOAELs or LOAELs (N(L)OAELs) observed between rat and rabbit developmental toxicity studies performed according to OECD guidelines could just as well be caused by study replication errors, and not necessarily by differences in species sensitivity. This conclusion follows from an analysis of a database with rat and rabbit developmental toxicity studies for over 1000 industrial chemicals, pesticides, veterinary drugs and human pharmaceuticals, which included 143 compounds with multiple oral rat studies and 124 compounds with multiple oral rabbit studies. Our analysis confirms earlier findings that, on average over all compounds, rat and rabbit do not differ in sensitivity to developmental effects. There is substantial scatter in the correlation plots comparing rat and rabbit developmental N(L)OAELs, which is easily interpreted as species differences for individual compounds. However, for compounds tested twice in the same species, these N(L)OAELs may differ up to a factor of 25. Thus, potential interspecies differences in developmental N(L)OAEL will be overwhelmed by the reproducibility error, rendering the added value of a second species study questionable. As N(L)OAELs serve as point of departure (POD) for setting health-based guidance values in risk assessment, the large reproducibility error of N(L)OAELs should be taken into account by the introduction of an additional uncertainty factor. It is recommended to aim for reducing the reproducibility error by applying dose-response (BMD) analysis, optimize study designs and harmonize study protocols. •Differences in LOAELs between rat and rabbit developmental toxicity studies are mainly caused by study replication errors.•Potential interspecies differences in developmental NOAELs or LOAELs will be overwhelmed by the reproducibility error.•Given the large replication error in NOAELs and LOAELs, the added value of a second species study is questionable.•The large reproducibility error of NOAELs and LOAELs warrants consideration of an additional uncertainty factor.•Aiming at a smaller reproducibility error of the in vivo developmental study is of paramount importance.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX